sequence analysis mutations translocations across breast cancer subtypes 
breast carcinoma leading cause cancer-related mortality women worldwide estimated million new cases deaths alone1 malignancy represents heterogeneous group tumours characteristic molecular features prognosis responses available therapy2- recurrent somatic alterations breast cancer described including mutations copy number alterations notably erbb2 amplifications first successful therapy target defined genomic aberration5 previous dna sequencing studies breast cancer genomes revealed additional candidate mutations gene rearrangements6- report whole-exome sequences dna human breast cancers diverse subtypes patients mexico vietnam compared matched-normal dna together whole-genome sequences breast cancer/normal pairs beyond confirming recurrent somatic mutations pik3ca11 tp536 akt112 gata313 map3k110 discovered recurrent mutations cbfb transcription factor gene deletions partner runx1 furthermore identified recurrent magi3-akt3 fusion enriched triple-negative breast cancer lacking oestrogen progesterone receptors erbb2 expression magi3-akt3 fusion leads constitutive activation akt kinase abolished treatment atp-competitive akt small-molecule inhibitor 
